FindTrial
Sign In

Effect of palliative care in the form of personalised supportive care and counselling by a medical student on quality of life of patients of non cancer long term lung diseases compared to standard care being routinely received.

To determine the effect of medical-student-volunteer led palliative care along with standard care on quality of life of patients suffering from end-stage non-malignant chronic pulmonary diseases compared to those receiving standard care alone - A pilot randomised control trial.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/09/045940
Enrollment
30
Registered
2022-09-27
Start date
Unknown
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J449- Chronic obstructive pulmonary disease, unspecified

Interventions

Intervention1: Counselling: Palliative care in the form of counselling mainly, alongside patient evaluation, evaluation of needs of the patient and catering to them with ongoing medication dose adjust

Sponsors

JIPMER puducherry
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. All adult patients (age >18 years) admitted or receiving follow up care for chronic pulmonary diseases. 2. Types of diseases included in chronic pulmonary diseases are chronic obstructive pulmonary diseases, pneumonia, tuberculosis, interstitial lung diseases, pneumoconiosis, pulmonary circulatory diseases.

Exclusion criteria

Exclusion criteria: 1. Patients suffering from carcinoma lung. 2. Patients in early stages of diseases with expected survival for more than 3 years as assessed by the treating physician.

Design outcomes

Primary

MeasureTime frame
Palliative performance scale and FACIT-sp scale will be used to evaluate outcomes of the study to evaluate improvement in patients quality of lifeTimepoint: 1. Baseline values will be noted at the first contact with the primary investigator. 2. Another set of values will be noted 4 weeks later, at the follow up contact. This will be post intervention value.—

Secondary

MeasureTime frame
Patient health questionnaire-9 will be used to evaluate secondary outcome, to evaluate quality of life changes following interventionTimepoint: 1st baseline values will be taken at the first contact of investigator with patients. 2. Post intervention values will be recorded 4 weeks following the first contact.—

Countries

India

Contacts

Public ContactNishtha Mahajan

JIPMER PONDICHERRY

sarkarsonaligh@gmail.com9442174663

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026